NFKB1 and diabetes mellitus: Furthermore, LPS-Exos have also been found to affect the NF-κB or NLRP3 signaling pathway, regulate macrophage polarization, reduce inflammation and facilitate tissue repair in kidney injury, diabetes, nerve injury, and myocardial infarction disease models [14, 34, 40, 56].